EGFR Protein

EGFR Protein

Pathway Diagram

Overview

Epidermal growth factor receptor (EGFR, also known as HER1 or ErbB1) is a transmembrane receptor tyrosine kinase (RTK) that belongs to the ErbB family of receptors. The EGFR protein is encoded by the EGFR gene located on chromosome 7 and is approximately 170 kilodaltons in molecular weight. As a prototype receptor tyrosine kinase, EGFR functions as a critical signaling hub that integrates extracellular growth factor signals into intracellular responses. The receptor exists primarily as a monomeric protein on the cell surface but undergoes ligand-induced dimerization and activation. EGFR is expressed broadly across tissues, including the central and peripheral nervous systems, making it particularly relevant to neurobiological processes and disease mechanisms.

Function/Biology

EGFR Protein

Pathway Diagram

Overview

Epidermal growth factor receptor (EGFR, also known as HER1 or ErbB1) is a transmembrane receptor tyrosine kinase (RTK) that belongs to the ErbB family of receptors. The EGFR protein is encoded by the EGFR gene located on chromosome 7 and is approximately 170 kilodaltons in molecular weight. As a prototype receptor tyrosine kinase, EGFR functions as a critical signaling hub that integrates extracellular growth factor signals into intracellular responses. The receptor exists primarily as a monomeric protein on the cell surface but undergoes ligand-induced dimerization and activation. EGFR is expressed broadly across tissues, including the central and peripheral nervous systems, making it particularly relevant to neurobiological processes and disease mechanisms.

Function/Biology

EGFR activation occurs through binding of multiple ligands including epidermal growth factor (EGF), transforming growth factor-alpha (TGF-α), amphiregulin, betacellulin, heparin-binding EGF-like growth factor (HB-EGF), and epiregulin. Ligand binding induces conformational changes that expose dimerization interfaces, leading to homo- or heterodimerization with other ErbB family members (ErbB2, ErbB3, ErbB4). Receptor dimerization brings the intracellular kinase domains into proximity, enabling trans-autophosphorylation at multiple tyrosine residues within the kinase activation loop and the C-terminal tail.

Phosphorylated EGFR tyrosines serve as docking sites for adaptor proteins containing SH2 or PTB domains, recruiting and activating downstream signaling cascades. The primary EGFR-activated pathways include the RAS/RAF/MEK/ERK mitogen-activated protein kinase (MAPK) pathway, which regulates proliferation and gene expression; the phosphoinositide 3-kinase/protein kinase B (PI3K/AKT) pathway, which promotes survival and metabolic reprogramming; the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, which modulates transcriptional responses; and phospholipase C-gamma (PLCγ) signaling, which increases intracellular calcium. In neurons specifically, EGFR signaling participates in dendritic morphogenesis, synaptogenesis, and activity-dependent plasticity.

Role in Neurodegeneration

EGFR dysfunction has been implicated in multiple neurodegenerative diseases through disrupted neuroprotection, impaired glial support, and altered inflammatory responses. In Alzheimer's disease, reduced EGFR signaling correlates with amyloid-beta accumulation and tau pathology progression. Compromised EGFR function in microglia and astrocytes impairs their capacity to clear amyloid-beta and provide trophic support to vulnerable neurons. In Parkinson's disease, loss of EGFR signaling in dopaminergic neurons and glial cells reduces neuroprotective responses to oxidative stress and neuroinflammation. Amyotrophic lateral sclerosis (ALS) pathology involves altered EGFR expression in motor neurons and microglia, contributing to excitotoxicity and reduced glial-mediated neuroprotection.

Molecular Mechanisms

EGFR's neuroprotective mechanisms involve multiple converging pathways. AKT activation promotes neuronal survival through phosphorylation and inactivation of pro-apoptotic proteins BAD and FoxO transcription factors. ERK1/2 phosphorylation drives expression of anti-apoptotic proteins and neurotrophic factors. EGFR also activates anti-inflammatory signaling in glial cells, suppressing nuclear factor-kappa B (NF-κB)-dependent production of pro-inflammatory cytokines and reactive oxygen species. In neurodegenerative contexts, loss of EGFR signaling capacity—whether through reduced ligand availability, impaired receptor expression, or diminished kinase activity—compromises these protective mechanisms, exacerbating neuronal vulnerability.

Clinical/Research Significance

Understanding EGFR biology has therapeutic implications for neurodegeneration. EGFR ligands and small-molecule EGFR kinase activators are being explored as neuroprotective interventions. Conversely, certain EGFR inhibitors used in cancer therapy have neurotoxic effects, highlighting the importance of EGFR in nervous system homeostasis. Research demonstrates that enhancing EGFR signaling in glial cells promotes neuroprotection, suggesting that glial-targeted EGFR modulation may benefit multiple neurodegenerative conditions.

Related Entities

ErbB2, ErbB3, ErbB4, Growth factor receptors, Receptor tyrosine kinases, PI3K/AKT signaling, RAS/MAPK signaling, Neuroinflammation, Neurodegeneration, Neuroprotection, Gliosis, Amyloid-beta, Tau pathology, Oxidative stress

Pathway Diagram

The following diagram shows the key molecular relationships involving EGFR Protein discovered through SciDEX knowledge graph analysis: